Canopy Growth Corporation (CGC)
| Market Cap | 458.59M |
| Revenue (ttm) | 203.04M |
| Net Income (ttm) | -238.19M |
| Shares Out | 377.86M |
| EPS (ttm) | -0.99 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,167,890 |
| Open | 1.180 |
| Previous Close | 1.200 |
| Day's Range | 1.150 - 1.190 |
| 52-Week Range | 0.844 - 2.380 |
| Beta | 2.32 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | May 29, 2026 |
About CGC
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7A... [Read more]
Financial Performance
In fiscal year 2025, Canopy Growth's revenue was 269.00 million, a decrease of -9.47% compared to the previous year's 297.15 million. Losses were -598.12 million, -9.00% less than in 2024.
Financial numbers in CAD Financial StatementsNews
Canopy Growth Stock Is Jumping. Is It Overdue for a Much Bigger Rally?
The pot stock is up over 30% in just the past month.
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth is a penny stock, so small price movements can lead to huge percentage changes. The marijuana company recently bought another company, extending its reach in medical marijuana.
'GIANT STEP FORWARD': Reclassification of medical cannabis lauded
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.' 00:00 Introduction & Re...
Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change
Akanda Corp. (NASDAQ: AKAN) shares continued to surge today after U.S. regulators moved to reclassify certain marijuana products, fueling a broader rally in cannabis stocks. • Akanda stock is chargin...
'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana
The Trump administration reclassified medical marijuana as a less dangerous drug on Thursday. FDA-approved and state-licensed medical marijuana was rescheduled from a Schedule I drug to the less stric...
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling Food and Drug Administration-approved and state-licensed medical cannabis products as a...
Cannabis Stocks Soared—Than Sank. Here's What Investors Need to Know.
Marijuana-related investments were flying high this morning. Then they reversed course, and quickly.
Cannabis rescheduling fuels optimism across industry
The U.S. Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of reclassifying the drug as less dangerous in one of the biggest changes t...
What's Going On With Canopy Growth Stock Thursday?
Canopy Growth Corp (NASDAQ:CGC) shares are falling Thursday morning, pulling back following Wednesday's strength, after a potential major shift in U.S. cannabis policy put the sector in focus. Here's ...
Canopy Growth (CGC) Shares Surge on Rescheduling of Medical Marijuana
Canopy Growth (CGC) Shares Surge on Rescheduling of Medical Marijuana
‘There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “Canopy” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced a refresh of Tweed, one of Canada's most recogni...
Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know
Akanda Corp. (NASDAQ: AKAN) shares are trending on Thursday. AKAN shares climbed 33.69% to $13.65 after the bell on Wednesday. The after-hours gain follows a 214.15% surge during the regular session,...
Trump's Marijuana Reclassification Plan Sparks Cannabis ETF Rally—Is A Breakout Finally Here?
Cannabis ETFs surged Wednesday after Axios reported that the Donald Trump administration is set to reclassify marijuana as a Schedule III drug as soon as today. The rally was seen across the cannabis ...
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe cou...
Canopy Growth Stock Surges On Impending Trump Administration Marijuana Reclassification: Report
Shares of Canopy Growth Corp (NASDAQ:CGC) are trading sharply higher Wednesday afternoon following news of a potential major shift in federal cannabis policy. Here's what investors need to know.
Canopy Growth Stock Surges On Impending Trump Administration Marijuana Reclassification: Report
Shares of Canopy Growth (NASDAQ: CGC) are surging Wednesday afternoon following news of a potential major shift in federal cannabis policy. ... Full story available on Benzinga.com
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Trump To Reclassify Marijuana 'As Soon As Wednesday,' But Prediction Markets Are Skeptical
Cannabis stocks ripped today on an Axios scoop that President Donald Trump will move to reclassify marijuana as soon as this week. Tilray Brands (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC) and Crono...
From $500 to $1: Is Canopy Growth a Dead Stock Walking or the Ultimate Turnaround Play?
Canopy Growth has lost more than 99% of its value during the past five years. A partial rebound may be possible, but don't discount the risk of long-standing issues placing additional pressure.
3 Marijuana Stocks That Could Help You Make A Profit In Cannabis
Marijuana stock investors are still in a position where volatility and speculation control the outcome. Especially with all the laws and regulatory changes that have transformed the cannabis industry....
3 Canadian Marijuana Stocks For Better Cannabis Investing 2026
Marijuana stock investors who have been trading and holding over the years know this sector holds potential. Now, potential doesn't put money in your pocket, but progressive and profitable companies t...
Best Canadian Cannabis Stocks for Potential Breakouts in March 2026
The Canadian cannabis sector continues evolving as global opportunities expand. Many companies are now positioning for U.S. entry. Additionally, federal reform discussions in the United States remain ...
Canopy Growth Unveils New Brand ‘Deelish': High THC, Everyday Price
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the e...
Thinking About Buying Canopy Growth Stock? You May Want to Wait for This to Happen First
Marijuana legalization in the U.S. isn't likely to happen anytime soon, and that's weighing on Canopy Growth's stock. The company's results have been abysmal, and there's little reason to be optimisti...
Canopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis Clinic
SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced that its Apollo Cannabis Clinics (“Apollo”) has been named...